Pulmonx LUNG
NASDAQ LUNG
$2.78 -0.02 (-0.71%)
As of: Nov 10, 2026 · 2:50 PM EST

Pulmonx (LUNG) Convertible Debt (2020)

Updated

Pulmonx (LUNG) recorded Convertible Debt of $29.75 million in Q3 2020.

Analysis

Pulmonx (LUNG) Convertible Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn
10 Pulmonx 116.67 Mn -202.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 29.75 Mn
API Access

Pulmonx Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=LUNG&period=max&api_key=YOUR_API_KEY